
Novo Nordisk (NYSE: NVO)
Novo Nordisk Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Novo Nordisk Company Info
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
News & Analysis
How GoodRx Makes Money
Meet the 1.4% Yield Dividend Stock That Could Soar in 2026
The company is one of two major players in the rapidly growing obesity drug market. Yet, the stock has lost half its value.
The Smartest Growth Stock to Buy With $100 Right Now
This beaten-down drugmaker is well positioned to turn things around.
3 Top Healthcare Stocks to Buy in October
Healthcare stocks haven't been very popular this year. It could be a great time to buy some of the industry's leaders.
Should You Buy Novo Nordisk Right Now?
The fallen pharma giant could make a big comeback in 2026.
The Largest Healthcare Companies by Market Cap in October 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
Eastover Opens a Brand New $3.3 Million Novo Nordisk Position
Carolina Wealth Makes a Big $6 Million Bet on Novo Nordisk (NYSE: NVO)
Valuation
Earnings Transcripts
Novo Nordisk (NVO) Q4 2024 Earnings Call Transcript
NVO earnings call for the period ending December 31, 2024.
Novo Nordisk (NVO) Q3 2024 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2024.
Novo Nordisk (NVO) Q2 2024 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2024.
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2024.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.